CMO Roundtable: What’s Next for the Contract Manufacturing Industry
West Pharmaceutical Services | March 21, 2017
2016 saw a continued increase in outsourcing manufacturing operations to contract manufacturers in order for pharmaceutical companies to cut back on in-house costs and capacity while maintaining quality and improving time to market. With increased pressures for companies to reduce cost while still expanding core competencies (such as R&D) and marketing, outsourcing continues to make a name for itself in the industry.